Astrana Health, Inc.

Astrana Health, Inc.

ASTH
Astrana Health, Inc.US flagNASDAQ Capital Market
39.35
USD
+0.61
- -
1.95BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
6.78
7.5
9.52
11.03
15.81
16.15
10.17
17.71
25.43
29.69
42.91
64.83
62.26
Basic EPS, GAAP
- -
-0.37
-1.59
-1.49
0.8
0.33
0.41
-0.65
1.58
1
1.3
0.91
0.46
0.45
Free Cash Flow per Basic Share
- -
-0.07
-0.36
-1.4
1.54
0.74
0.36
1.24
1.17
1.32
0.85
0.93
2.13
1.42
Dividend per Share
- -
0.12
- -
- -
0.32
0.54
1.78
1.41
0.71
0.31
1.33
0.09
0.16
0.04
Book Value per Share
-0.25
-0.58
-0.88
-1.88
4.95
5.22
5.33
7.83
10.04
11.65
13.11
14.87
15.94
- -
Tangible Book Value per Share
-0.36
-1.31
-1.55
-2.46
-4.13
-2.66
-4.18
0.11
2.67
4.22
5.63
3.66
-7.3
- -
Basic Weighted Avg Shares
- -
5
6
6
32
33
35
36
44
45
47
47
49
46
Sales/Revenue/Turnover
- -
33
44
57
356
520
561
370
774
1,144
1,387
2,035
3,182
2,872
Operating Margin (%)
- -
-2.1
-16.5
-18.35
10.55
17.74
6.14
1.64
12.69
9.11
6.1
4.39
2.47
2.3
Depreciation Expense
- -
- -
- -
1
19
19
18
18
18
18
18
28
46
47
Net Income, GAAP
- -
-2
-9
-9
26
11
14
-24
69
45
61
43
22
21
Effective Tax Rate (%)
- -
- -
- -
- -
7.82
27.06
31.61
103.54
40.76
47.19
35.61
38.22
39.21
36.84
Profit Margin (%)
- -
-5.46
-21.21
-15.62
7.24
2.08
2.52
-6.42
8.91
3.95
4.38
2.12
0.71
0.72
Working Capital
6
4
6
- -
35
101
224
224
290
280
243
273
248
- -
LT Debt
6
8
- -
5
1
14
244
246
197
225
296
456
1,022
- -
Total Equity
-2
-1
9
- -
336
407
361
445
511
559
411
514
558
- -
Return on Invested Capital (%)
- -
- -
- -
- -
19.49
17.3
4.47
-0.03
8.18
7.32
7.15
6.43
3.64
8.48
Return on Capital (%)
- -
- -
- -
- -
3.32
-10.01
2.66
-7.15
13.4
6.51
9.73
6.62
3.91
10.81
Return on Common Equity (%)
- -
- -
- -
- -
- -
6.36
7.59
-9.09
17.7
9.12
10.5
6.5
3.01
5.44

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
56
55
- -
LT Borrowings
991
980
- -
LT Finance Leases
32
30
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
49
49
49
Market Capitalization
1,213
1,200
2,272

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
863
1,004
- -
Cash, Cash Equivalents & STI
429
478
- -
Accounts Receivable, Net
374
467
- -
Inventories
- -
- -
- -
Total Current Liabilities
615
745
- -
Payables & Accruals
165
201
- -
ST Debt
56
55
- -
Deferred Revenue
3
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12,425.84%
6.28%
8.59%
Free Cash Flow
-8.68%
28.86%
136.58%
Net Income, GAAP
-115.47%
-93.41%
-47.89%
Sales/Revenue/Turnover
85.18%
56.23%
56.39%
Total Cash Common Dividend
- -
50%
95.37%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
404
486
479
665
2,035
2025
620
655
956
951
3,182
2026
965
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.31
0.4
0.34
-0.15
0.91
2025
0.14
0.19
0.01
0.12
0.46
2026
0.3
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.04
- -
0.04
0.09
2025
0.11
0.02
- -
0.03
0.16
2026
- -
- -
- -
- -
- -

Company Description

CEO
Brandon K. Sim
Full Time Employees
3,000
Sector
Healthcare
Industry
Medical - Care Facilities
Address
1668 S. Garfield Avenue Alhambra CA United States of America 91801
IPO Date
Mar 11, 2009
Business
Astrana Health, Inc. operates as a physician-centric, technology-powered, risk-bearing healthcare management company primarily in the United States. The company delivers an integrated healthcare delivery platform offering a comprehensive spectrum of medical services including primary care; multi-specialty care; immediate care; radiology; laboratory services; and care coordination for patients. It serves a network of primary care physicians, specialist physicians, extenders, hospitalists, and healthcare providers, supporting patients covered by Medicare, Medicaid, private insurance, and uninsured populations. Astrana operates through three segments: Care Partners, which includes value-based care arrangements facilitating provider performance in population health management; Care Delivery, encompassing direct medical services through physician networks; and Care Enablement, which provides technology and administrative support services to healthcare providers. Founded in 1994 and headquartered in Alhambra, California, Astrana Health focuses on delivering high-quality, cost-effective patient-centered care by leveraging proprietary end-to-end technology solutions that enable providers to succeed in value-based care environments. In the last 1-2 years, Astrana Health has undergone significant strategic changes. The company rebranded from Apollo Medical Holdings, Inc. to Astrana Health, Inc. in February 2024 to reflect its expanded scope and technology-driven care model. It entered into key strategic partnerships, such as a nationwide alliance with Elation Health to expand its support infrastructure for primary care physicians. Astrana also acquired Prospect Health System and Collaborative Health Systems to broaden its care delivery network and enhance its integrated healthcare platform. These moves coincide with its focus on scaling AI-enabled healthcare delivery and strengthening leadership to bolster its technology infrastructure. Astrana Health’s latest reported financials for 2024 show robust revenue growth with total revenue exceeding $2 billion, driven mainly by its Care Partners segment. The company continues to advance patient care quality and provider well-being through technology-enhanced services while expanding its presence across U.S. markets. Astrana Health’s industry positioning is within healthcare providers and services, specializing in value-based care models that emphasize risk-sharing, cost-efficiency, and quality outcomes. Its customer base includes healthcare providers, hospitals, physician groups, health plans, and patients with complex chronic conditions, especially within Medicare Advantage and other public and private insurance frameworks. The company’s targeted geographic operations span across the United States. Leadership enhancements in 2025 underscore a strategic emphasis on scaling AI and technology capabilities to sustain market competitiveness and care innovation. This description encompasses Astrana Health’s core activities, detailed product/service offerings, recent corporate developments, and operational context based on the latest publicly available information.

Company News

  • Astrana Health: 81% Full-Risk And Profitable

  • Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

  • Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

  • Astrana Health Q2 Earnings Call Highlights

  • Astrana Health, Inc. Reports Second Quarter 2026 Results

  • A Look at Astrana Health Inc (ASTH) After 3.0% Decline -- GF Value $83.77 vs Price $35.52

  • Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call

  • Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth

  • Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year

  • Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains?

  • Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth

  • Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations

  • Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

  • Astrana Health, Inc. Announces Appointment of Interim National Medical Director

  • Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care

  • Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript

  • Astrana Health, Inc. (ASTH) Surpasses Q1 Earnings and Revenue Estimates

  • Astrana Health, Inc. Reports First Quarter 2026 Results

  • Is the Options Market Predicting a Spike in Astrana Health Stock?

  • Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call